These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
208 related items for PubMed ID: 25417239
21. Nomogram model for predicting cause-specific mortality in patients with stage I small-cell lung cancer: a competing risk analysis. Li J, Zheng Q, Zhao X, Zhao J, An T, Wu M, Wang Y, Zhuo M, Zhong J, Yang X, Jia B, Chen H, Dong Z, Wang J, Chi Y, Zhai X, Wang Z. BMC Cancer; 2020 Aug 24; 20(1):793. PubMed ID: 32838776 [Abstract] [Full Text] [Related]
22. Competing Risk of Death in Elderly Patients with Newly Diagnosed Stage I Breast Cancer. Wasif N, Neville M, Gray R, Cronin P, Pockaj BA. J Am Coll Surg; 2019 Jul 24; 229(1):30-36.e1. PubMed ID: 30930100 [Abstract] [Full Text] [Related]
23. Cancer survival in Germany and the United States at the beginning of the 21st century: an up-to-date comparison by period analysis. Gondos A, Arndt V, Holleczek B, Stegmaier C, Ziegler H, Brenner H. Int J Cancer; 2007 Jul 15; 121(2):395-400. PubMed ID: 17372898 [Abstract] [Full Text] [Related]
24. Effect of a dementia diagnosis on survival of older patients after a diagnosis of breast, colon, or prostate cancer: implications for cancer care. Raji MA, Kuo YF, Freeman JL, Goodwin JS. Arch Intern Med; 2008 Oct 13; 168(18):2033-40. PubMed ID: 18852406 [Abstract] [Full Text] [Related]
25. Crude probability of death for cancer patients by spread of disease in New South Wales, Australia 1985 to 2014. Yu XQ, Dasgupta P, Kahn C, Kou K, Cramb S, Baade P. Cancer Med; 2021 Jun 13; 10(11):3524-3532. PubMed ID: 33960140 [Abstract] [Full Text] [Related]
26. A New Personalized Oral Cancer Survival Calculator to Estimate Risk of Death From Both Oral Cancer and Other Causes. Davies L, Hankey BF, Wang Z, Zou Z, Scott S, Lee M, Cho H, Feuer EJ. JAMA Otolaryngol Head Neck Surg; 2023 Nov 01; 149(11):993-1000. PubMed ID: 37429022 [Abstract] [Full Text] [Related]
27. Misclassification of the actual causes of death and its impact on analysis: A case study in non-small cell lung cancer. Tan KS. Lung Cancer; 2019 Aug 01; 134():16-24. PubMed ID: 31319976 [Abstract] [Full Text] [Related]
28. Variation, precision and validity of 1-year survival estimates for lung, breast, colon and prostate cancer in South East England primary care trusts. Lake J, Mak V, Møller H, Davies EA. Public Health; 2012 Jan 01; 126(1):57-63. PubMed ID: 22153886 [Abstract] [Full Text] [Related]
29. How can we make cancer survival statistics more useful for patients and clinicians: an illustration using localized prostate cancer in Sweden. Eloranta S, Adolfsson J, Lambert PC, Stattin P, Akre O, Andersson TM, Dickman PW. Cancer Causes Control; 2013 Mar 01; 24(3):505-15. PubMed ID: 23296456 [Abstract] [Full Text] [Related]
30. Assessing the utility of cancer-registry-processed cause of death in calculating cancer-specific survival. Hu CY, Xing Y, Cormier JN, Chang GJ. Cancer; 2013 May 15; 119(10):1900-7. PubMed ID: 23408226 [Abstract] [Full Text] [Related]
31. Survival of patients newly diagnosed with colorectal cancer and with a history of previous cancer. Pruitt SL, Gerber DE, Zhu H, Heitjan DF, Maddineni B, Xiong D, Singal AG, Tavakkoli A, Halm EA, Murphy CC. Cancer Med; 2021 Jul 15; 10(14):4752-4767. PubMed ID: 34190429 [Abstract] [Full Text] [Related]
32. The impact of state-specific life tables on relative survival. Stroup AM, Cho H, Scoppa SM, Weir HK, Mariotto AB. J Natl Cancer Inst Monogr; 2014 Nov 15; 2014(49):218-27. PubMed ID: 25417235 [Abstract] [Full Text] [Related]
33. Cancer net survival on registry data: use of the new unbiased Pohar-Perme estimator and magnitude of the bias with the classical methods. Roche L, Danieli C, Belot A, Grosclaude P, Bouvier AM, Velten M, Iwaz J, Remontet L, Bossard N. Int J Cancer; 2013 May 15; 132(10):2359-69. PubMed ID: 22961565 [Abstract] [Full Text] [Related]
34. Differential prognostic impact of comorbidity. Read WL, Tierney RM, Page NC, Costas I, Govindan R, Spitznagel EL, Piccirillo JF. J Clin Oncol; 2004 Aug 01; 22(15):3099-103. PubMed ID: 15284260 [Abstract] [Full Text] [Related]
35. Incorporating competing risk theory into evaluations of changes in cancer survival: making the most of cause of death and routinely linked sociodemographic data. Wright CM, Nowak AK, Halkett G, Moorin RE. BMC Public Health; 2020 Jun 26; 20(1):1002. PubMed ID: 32586298 [Abstract] [Full Text] [Related]
36. Cost of care for elderly cancer patients in the United States. Yabroff KR, Lamont EB, Mariotto A, Warren JL, Topor M, Meekins A, Brown ML. J Natl Cancer Inst; 2008 May 07; 100(9):630-41. PubMed ID: 18445825 [Abstract] [Full Text] [Related]
37. Competing risks of death in patients with localized renal cell carcinoma: a comorbidity based model. Kutikov A, Egleston BL, Canter D, Smaldone MC, Wong YN, Uzzo RG. J Urol; 2012 Dec 07; 188(6):2077-83. PubMed ID: 23083850 [Abstract] [Full Text] [Related]
38. Conditional survival of cancer patients: an Australian perspective. Yu XQ, Baade PD, O'Connell DL. BMC Cancer; 2012 Oct 08; 12():460. PubMed ID: 23043308 [Abstract] [Full Text] [Related]
39. Survival benefit of radical prostatectomy in patients with localized prostate cancer: estimations of the number needed to treat according to tumor and patient characteristics. Abdollah F, Sun M, Schmitges J, Thuret R, Bianchi M, Shariat SF, Briganti A, Jeldres C, Perrotte P, Montorsi F, Karakiewicz PI. J Urol; 2012 Jul 08; 188(1):73-83. PubMed ID: 22578732 [Abstract] [Full Text] [Related]
40. Adequate lymph node evaluation in the elderly is associated with improved survival in patients with stage I-III colon cancer: A validation study using the National Cancer Data Base. Reha J, Mukkamalla SKR, Rathore R, Somasundar PS. Eur J Surg Oncol; 2018 Jan 08; 44(1):148-156. PubMed ID: 29198492 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]